Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07166939 · ClinicalTrials.gov registry record · Phase 4
45th Multicenter Airway Research Collaboration
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 1,860
- Enrollment target
NCT07166939: Recruiting Phase 4 study, sponsored by Massachusetts General Hospital.
NCT07166939 is a Phase 4 study that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 1,860 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (259% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07166939, a Phase 4 study, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 1,860 participants
- Enrollment target
Study Summary
The study is a randomized controlled trial on the effect of emergency department initiation of Airsupra on acute asthma "recurrence" at 3 months and other related outcomes (acute asthma relapse, asthma control).
Primary Outcome
any urgent or unscheduled visit to a clinician for worsening asthma symptoms during the 3 months after the index ED visit
Interventions
- DRUG Airsupra
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,860 participants |
| Start Date | 2025-11-07 |
| Est. Completion | 2027-06 |
| Phase | Phase 4 |
What NCT07166939 shows while recruiting
NCT07166939 is an interventional study that assigns participants to a tested intervention. Its 1,860 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (259% higher).
The record links to 0 conditions, and to 1 intervention - of which Airsupra is the first listed.
NCT07166939 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07166939 about?
NCT07166939 is a clinical study titled "45th Multicenter Airway Research Collaboration". The study is a randomized controlled trial on the effect of emergency department initiation of Airsupra on acute asthma "recurrence" at 3 months and other related outcomes (acute asthma relapse, asthma control).
What is the current status of trial NCT07166939?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 1,860 participants. The study started on 2025-11-07. Estimated completion is 2027-06.
What interventions are being tested in trial NCT07166939?
The interventions under investigation include: Airsupra (DRUG).
Who is sponsoring clinical trial NCT07166939?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07166939's enrollment target sits among peer trials
1,860 45th of 2000 higher than 1,956 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06465810 · 1,850 participants
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- NCT06580080 · 1,850 participants · NA
Evaluation of Are You Ready?
- NCT07203313 · 1,872 participants · NA
Evaluation of Aim to Play, a User-Friendly Digital Application for Teacher Skills Training and Physical Education Activities for 3-5 Grade Students
- NCT05675410 · 1,875 participants · Phase 3
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI